pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 9·1 min read
save

K Health expands AI chatbot from symptom checker to hospital use

Jun 9, 2026·read at Endpoints ↗Positive

K Health, a startup founded in 2016 as a symptom checking tool, is now deploying its AI chatbot within hospital environments.

The shift follows a broader surge in AI driven virtual doctors that patients can converse with, a trend that has gathered momentum over the past year.

By embedding its chatbot into clinical workflows, K Health hopes to aid clinicians with patient triage and information gathering, though specific deployment details remain limited.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “How K Health moved AI chatbots into hospitals”

read at Endpoints ↗
85 words · retrieved Jun 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 7h agoSanofi's new R&D chief: Western pharma should rethink China's drug pipeline roleEndpoints
  • 8h agoNew FDA framework tilts toward consistency over flexibilityEndpoints
  • 10h agoVerastem makes its stand as a RevMed competitor in pancreatic cancerEndpoints
  • 12h agoUltragenyx's second PRV sale; Biomea's oral GLP-1 data leads to stock slumpEndpoints
  • 13h agoVir makes solid tumor T cell engager deal with GileadEndpoints